January 10, 2023
Krushna Patra is the first University of Cincinnati researcher to receive the prestigious National Cancer Institute MERIT Award to continue his research on how mutations help pancreatic cancer grow.
January 10, 2023
Parkinson's News Today highlighted results of a recent trial, led in the U.S. by the University of Cincinnati's Alberto Espay, that found a liquid drug formulation was more effective than an oral formulation to control symptoms of Parkinson's disease.
December 20, 2022
The University of Cincinnati's Alberto Espay joined 55KRC's Simply Medicine program to discuss stiff person syndrome following singer Céline Dion's announcement she has been diagnosed with the neurological condition.
October 10, 2022
Local 12 News and 55KRC's Simply Medicine podcast highlighted the the University of Cincinnati Gardner Neuroscience Institute's transformation into a Learning Health System, beginning with work in epilepsy.
December 9, 2022
The University of Cincinnati's Pooja Khatri spoke with CNN about a recent study that found statins can reduce the risk of an intracerebral hemorrhage.
March 9, 2023
KYTV News in Springfield, Missouri highlighted the University of Cincinnati's epilepsy transition clinic that helps guide patients as they move from pediatric to adult care.
November 28, 2023
The University of Cincinnati Cancer Center's Robert Van Haren joined the Research Evangelist podcast to discuss advancements in lung cancer care and research to improve accessibility to treatments.
November 27, 2023
The University of Cincinnati Cancer Center's Andrew Frankart, MD, is leading a new clinical trial that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.
November 27, 2023
Local 12 recently spoke with the University of Cincinnati's Andrew Waters and Pancreatic Cancer Action Network volunteers to discuss ongoing pancreatic cancer research and funding support during Pancreatic Cancer Awareness Month.
November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.